Skip to main content

Management of Severe Anoperineal Disease

  • Chapter
  • First Online:
Mastery of IBD Surgery
  • 518 Accesses

Abstract

Perianal involvement can occur in up to 42% of patients with Crohn’s disease and has the potential to cause significant life impairment. Close to 90% of patients with anoperineal Crohn’s disease require surgical intervention at some point in their lifetime, and up to 38% of patients with complex perianal fistulas undergo fecal stream diversion. This chapter focuses on surgical treatment of severe perianal Crohn’s disease (pCD) with a goal to compare seton placement with temporary fecal diversion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Platell C, Mackay J, Collopy B, Fink R, Ryan P, Woods R. Anal pathology in patients with Crohn’s disease. ANZ J Surg. 1996;66(1):5–9. https://doi.org/10.1111/j.1445-2197.1996.tb00690.x.

    Article  CAS  Google Scholar 

  2. Lapidus A, Bernell O, Hellers G, Löfberg R. Clinical course of colorectal Crohn’s disease: a 35-year follow-up study of 507 patients. Gastroenterology. 1998;114(6):1151–60.. http://www.ncbi.nlm.nih.gov/pubmed/9609751. Accessed 5 June 2018.

    Article  CAS  Google Scholar 

  3. Schwartz DA, Loftus EV, Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122(4):875–80. http://www.ncbi.nlm.nih.gov/pubmed/11910338. Accessed 17 June 2018.

    Article  Google Scholar 

  4. Michelassi F, Melis M, Rubin M, Hurst RD. Surgical treatment of anorectal complications in Crohn’s disease. Surgery. 2000;128(4):597–603. https://doi.org/10.1067/msy.2000.108779.

    Article  CAS  PubMed  Google Scholar 

  5. Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RCG, Kamm MA. The clinical course of fistulating Crohn’s disease. Aliment Pharmacol Ther. 2003;17(9):1145–51. http://www.ncbi.nlm.nih.gov/pubmed/12752351. Accessed 17 June 2018.

    Article  CAS  Google Scholar 

  6. Ardizzone S, Maconi G, Colombo E, Manzionna G, Bollani S, Bianchi Porro G. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis. 2004;10(2):91–6.. http://www.ncbi.nlm.nih.gov/pubmed/15168807. Accessed 17 June 2018.

    Article  Google Scholar 

  7. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn’s disease. Gastroenterology. 2003;125(5):1508–30. https://doi.org/10.1016/j.gastro.2003.08.025.

    Article  PubMed  Google Scholar 

  8. Irvine EJ. Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol. 1995;20(1):27–32.. http://www.ncbi.nlm.nih.gov/pubmed/7884173. Accessed 17 June 2018.

    Article  CAS  Google Scholar 

  9. Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn’s disease: monitoring disease activity. Aliment Pharmacol Ther. 2003;17(Suppl 2):11–7. http://www.ncbi.nlm.nih.gov/pubmed/12786607. Accessed 17 June 2018.

    Article  Google Scholar 

  10. van Dongen LM, Lubbers EJ. Perianal fistulas in patients with Crohn’s disease. Arch Surg. 1986;121(10):1187–90.. http://www.ncbi.nlm.nih.gov/pubmed/3767650. Accessed 17 June 2018.

    Article  Google Scholar 

  11. Bernard D, Morgan S, Tassé D. Selective surgical management of Crohn’s disease of the anus. Can J Surg. 1986;29(5):318–21.. http://www.ncbi.nlm.nih.gov/pubmed/3756650. Accessed 17 June 2018.

    CAS  PubMed  Google Scholar 

  12. Radcliffe AG, Ritchie JK, Hawley PR, Lennard-Jones JE, Northover JM. Anovaginal and rectovaginal fistulas in Crohn’s disease. Dis Colon Rectum. 1988;31(2):94–9.. http://www.ncbi.nlm.nih.gov/pubmed/3338350. Accessed 17 June 2018.

    Article  CAS  Google Scholar 

  13. Fry RD, Shemesh EI, Kodner IJ, Timmcke A. Techniques and results in the management of anal and perianal Crohn’s disease. Surg Gynecol Obstet. 1989;168(1):42–8.. http://www.ncbi.nlm.nih.gov/pubmed/2909131. Accessed 17 June 2018.

    CAS  PubMed  Google Scholar 

  14. Williams JG, MacLeod CA, Rothenberger DA, Goldberg SM. Seton treatment of high anal fistulae. Br J Surg. 1991;78(10):1159–61. https://doi.org/10.1002/bjs.1800781004.

    Article  CAS  PubMed  Google Scholar 

  15. Scott NA, Nair A, Hughes LE. Anovaginal and rectovaginal fistula in patients with Crohn’s disease. Br J Surg. 1992;79(12):1379–80.. http://www.ncbi.nlm.nih.gov/pubmed/1486446. Accessed 18 July 2018

    Article  CAS  Google Scholar 

  16. Pescatori M, Interisano A, Basso L, et al. Management of perianal Crohn’s disease. Results of a multicenter study in Italy. Dis Colon Rectum. 1995;38(2):121–4.. http://www.ncbi.nlm.nih.gov/pubmed/7851164. Accessed 17 June 2018.

    Article  CAS  Google Scholar 

  17. Koganei K, Sugita A, Harada H, Fukushima T, Shimada H. Seton treatment for perianal Crohn’s fistulas. Surg Today. 1995;25(1):32–6. https://doi.org/10.1007/BF00309382.

    Article  CAS  PubMed  Google Scholar 

  18. Sangwan YP, Schoetz DJ, Murray JJ, Roberts PL, Coller JA. Perianal Crohn’s Disease Results of Local Surgical Treatment. Dis Colon Rectum. 1996;39(5):529–35. https://doi.org/10.1007/BF02058706.

    Article  CAS  PubMed  Google Scholar 

  19. Scott HJ, Northover JM. Evaluation of surgery for perianal Crohn’s fistulas. Dis Colon Rectum. 1996;39(9):1039–43.. http://www.ncbi.nlm.nih.gov/pubmed/8797656. Accessed 18 July 2018

    Article  CAS  Google Scholar 

  20. Makowiec F, Jehle C, Becker H-D, Starlinger M. Perianal abscess in Crohn’s disease. 1997. https://insights.ovid.com/crossref?an=00003453-199740040-00011. Accessed 14 July 2018.

  21. Régimbeau J-M, Panis Y, Marteau P, Benoist S, Valleur P. Surgical treatment of anoperineal crohn’s disease: can abdominoperineal resection be predicted? 1999. https://ac.els-cdn.com/S1072751599000927/1-s2.0-S1072751599000927-main.pdf?_tid=435c0c76-74ea-496d-a29c-7b7d08933d70&acdnat=1531592691_ce33ece4e3fb4bf114a25cad6a9a4263. Accessed 14 July 2018.

  22. Takesue Y, Ohge H, Yokoyama T, Murakami Y, Imamura Y, Sueda T. Long-term results of seton drainage on complex anal fistulae in patients with Crohn’s disease. J Gastroenterol. 2002;37(11):912–5. https://doi.org/10.1007/s005350200153.

    Article  PubMed  Google Scholar 

  23. Shinozaki M, Koganei K, Fukushima T. Simultaneous anus and bowel operation is preferable for anal fistula in Crohn’s disease. J Gastroenterol. 2002;37(8):611–6. https://doi.org/10.1007/s005350200097.

    Article  PubMed  Google Scholar 

  24. Thornton M, Solomon MJ. Long-term indwelling seton for complex anal fistulas in Crohn’s disease. Dis Colon Rectum. 2005;48(3):459–63. https://doi.org/10.1007/s10350-004-0830-6.

    Article  PubMed  Google Scholar 

  25. Mueller MH, Geis M, Glatzle J, et al. Risk of fecal diversion in complicated perianal Crohn’s disease. J Gastrointest Surg. 2007;11(4):529–37. https://doi.org/10.1007/s11605-006-0029-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. van Koperen PJ, Safiruddin F, Bemelman WA, Slors JFM. Outcome of surgical treatment for fistula in ano in Crohn’s disease. Br J Surg. 2009;96(6):675–9. https://doi.org/10.1002/bjs.6608.

    Article  PubMed  Google Scholar 

  27. Löffler T, Welsch T, Mühl S, Hinz U, Schmidt J, Kienle P. Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn’s disease. Int J Color Dis. 2009;24(5):521–6. https://doi.org/10.1007/s00384-009-0638-x.

    Article  Google Scholar 

  28. Lozynskyy YS. Treatment algorithms in the case of perianal complications of Crohn’s disease. Dig Dis. 2009;27:565–70. https://doi.org/10.1159/000233299.

    Article  CAS  PubMed  Google Scholar 

  29. Rehg KL, Sanchez JE, Krieger BR, Marcet JE. Fecal diversion in perirectal fistulizing Crohn’s disease is an underutilized and potentially temporary means of successful treatment. Am Surg. 2009;75(8):715–8.. http://www.ncbi.nlm.nih.gov/pubmed/19725296. Accessed 13 July 2018.

    PubMed  Google Scholar 

  30. Galis-Rozen E, Tulchinsky H, Rosen A, et al. Long-term outcome of loose seton for complex anal fistula: a two-centre study of patients with and without Crohn’s disease. Color Dis. 2010;12(4):358–62. https://doi.org/10.1111/j.1463-1318.2009.01796.x.

    Article  CAS  Google Scholar 

  31. Molendijk I, Nuij VJAA, van der Meulen-de Jong AE, Janneke van der Woude C. Disappointing durable remission rates in complex Crohnʼs disease fistula. Inflamm Bowel Dis. 2014;20(11):2022–8. https://doi.org/10.1097/MIB.0000000000000148.

    Article  PubMed  Google Scholar 

  32. Papaconstantinou I, Kontis E, Koutoulidis V, Mantzaris G, Vassiliou I. Surgical management of fistula-in-ano among patients with Crohn’s disease: analysis of outcomes after fistulotomy or seton placement—single-center experience. Scand J Surg. 2017;106(3):211–5. https://doi.org/10.1177/1457496916665763.

    Article  CAS  PubMed  Google Scholar 

  33. Harper PH, Kettlewell MG, Lee EC. The effect of split ileostomy on perianal Crohn’s disease. Br J Surg. 1982;69(10):608–10.. http://www.ncbi.nlm.nih.gov/pubmed/7127043. Accessed 17 June 2018.

    Article  CAS  Google Scholar 

  34. Grant DR, Cohen Z, McLeod RS. Loop ileostomy for anorectal Crohn’s disease. Can J Surg. 1986;29(1):32–5. http://www.ncbi.nlm.nih.gov/pubmed/3940583. Accessed 17 June 2018.

    CAS  PubMed  Google Scholar 

  35. Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn’s disease. World J Surg. 2000;24(10):1258–62.. discussion 1262–3. http://www.ncbi.nlm.nih.gov/pubmed/11071472. Accessed 13 July 2018.

    Article  CAS  Google Scholar 

  36. Edwards CM, George BD, Jewell DP, Warren BF, Mortensen NJ, Kettlewell MG. Role of a defunctioning stoma in the management of large bowel Crohn’s disease. Br J Surg. 2000;87(8):1063–6. https://doi.org/10.1046/j.1365-2168.2000.01467.x.

    Article  CAS  PubMed  Google Scholar 

  37. Régimbeau JM, Panis Y, Cazaban L, et al. Long-term results of faecal diversion for refractory perianal Crohn’s disease. Color Dis. 2001;3(4):232–7. http://www.ncbi.nlm.nih.gov/pubmed/12790965. Accessed 18 July 2018

    Article  Google Scholar 

  38. Spivak J, Landers CJ, Vasiliauskas EA, et al. Antibodies to I2 predict clinical response to fecal diversion in Crohnʼs disease. Inflamm Bowel Dis. 2006;12(12):1122–30. https://doi.org/10.1097/01.mib.0000235833.47423.d7.

    Article  PubMed  Google Scholar 

  39. Hong MKH, Craig Lynch A, Bell S, et al. Faecal diversion in the management of perianal Crohn’s disease. Color Dis. 2011;13(2):171–6. https://doi.org/10.1111/j.1463-1318.2009.02092.x.

    Article  CAS  Google Scholar 

  40. Sauk J, Nguyen D, Yajnik V, et al. Natural history of perianal Crohnʼs disease after fecal diversion. Inflamm Bowel Dis. 2014;20(12):2260–5. https://doi.org/10.1097/MIB.0000000000000216.

    Article  PubMed  Google Scholar 

  41. Mennigen R, Heptner B, Senninger N, Rijcken E. Temporary fecal diversion in the management of colorectal and perianal Crohn’s disease. Gastroenterol Res Pract. 2015;2015:1–5. https://doi.org/10.1155/2015/286315.

    Article  Google Scholar 

  42. Gu J, Valente MA, Remzi FH, Stocchi L. Factors affecting the fate of faecal diversion in patients with perianal Crohn’s disease. Color Dis. 2015;17(1):66–72. https://doi.org/10.1111/codi.12796.

    Article  CAS  Google Scholar 

  43. Singh S, Ding NS, Mathis KL, et al. Systematic review with meta-analysis: faecal diversion for management of perianal Crohn’s disease. Aliment Pharmacol Ther. 2015;42(7):783–92. https://doi.org/10.1111/apt.13356.

    Article  CAS  PubMed  Google Scholar 

  44. Martí-Gallostra M, Myrelid P, Mortensen N, Keshav S, Travis SPL, George B. The role of a defunctioning stoma for colonic and perianal Crohn’s disease in the biological era. Scand J Gastroenterol. 2017;52(3):251–6. https://doi.org/10.1080/00365521.2016.1205127.

    Article  PubMed  Google Scholar 

  45. Bafford AC, Latushko A, Hansraj N, Jambaulikar G, Ghazi LJ. The use of temporary fecal diversion in colonic and perianal Crohn’s disease does not improve outcomes. Dig Dis Sci. 2017;62(8):2079–86. https://doi.org/10.1007/s10620-017-4618-7.

    Article  PubMed  Google Scholar 

  46. Topstad DR, Panaccione R, Heine JA, Johnson DRE, MacLean AR, Buie DW. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohnʼs disease. Dis Colon Rectum. 2003;46(5):577–83. https://doi.org/10.1007/s10350-004-6611-4.

    Article  PubMed  Google Scholar 

  47. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9(2):98–103.. http://www.ncbi.nlm.nih.gov/pubmed/12769443. Accessed 15 July 2018.

    Article  Google Scholar 

  48. van der Hagen SJ, Baeten CG, Soeters PB, Russel MGVM, Beets-Tan RG, van Gemert WG. Anti-TNF-α (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn’s disease: a preliminary report. Dis Colon Rectum. 2005;48(4):758–67. https://doi.org/10.1007/s10350-004-0828-0.

    Article  PubMed  Google Scholar 

  49. Hyder SA, Travis SPL, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohnʼs disease: results of combined surgical and infliximab treatment. Dis Colon Rectum. 2006;49(12):1837–41. https://doi.org/10.1007/s10350-006-0656-5.

    Article  PubMed  Google Scholar 

  50. Gaertner WB, Decanini A, Mellgren A, et al. Does infliximab infusion impact results of operative treatment for Crohnʼs perianal fistulas? Dis Colon Rectum. 2007;50(11):1754–60. https://doi.org/10.1007/s10350-007-9077-3.

    Article  PubMed  Google Scholar 

  51. Guidi L, Ratto C, Semeraro S, et al. Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience. Tech Coloproctol. 2008;12(2):111–7. https://doi.org/10.1007/s10151-008-0411-0.

    Article  CAS  PubMed  Google Scholar 

  52. Tougeron D, Savoye G, Savoye-Collet C, Koning E, Michot F, Lerebours E. Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn’s disease. Dig Dis Sci. 2009;54(8):1746–52. https://doi.org/10.1007/s10620-008-0545-y.

    Article  CAS  PubMed  Google Scholar 

  53. Sciaudone G, Di Stazio C, Limongelli P, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg. 2010;53(5):299–304.. http://www.ncbi.nlm.nih.gov/pubmed/20858373. Accessed 18 July 2018

    PubMed  PubMed Central  Google Scholar 

  54. Tanaka S, Matsuo K, Sasaki T, et al. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn’s disease: when and how were the seton drains removed? Hepato-Gastroenterology. 2010;57(97):3–7.. http://www.ncbi.nlm.nih.gov/pubmed/20422862. Accessed 14 July 2018

    CAS  PubMed  Google Scholar 

  55. Alvarez JA, Bermejo F, Algaba A, Hernandez MP, Grau M. Surgical repair and biological therapy for fecal incontinence in Crohn’s disease involving both sphincter defects and complex fistulas. J Crohns Colitis. 2011;5(6):598–607. https://doi.org/10.1016/j.crohns.2011.06.004.

    Article  CAS  PubMed  Google Scholar 

  56. Hotokezaka M, Ikeda T, Uchiyama S, Tsuchiya K, Chijiiwa K. Results of seton drainage and infliximab infusion for complex anal Crohn’s disease. Hepato-Gastroenterology. 2011;58(109):1189–92.. http://www.ncbi.nlm.nih.gov/pubmed/21937376. Accessed 18 July 2018

    CAS  PubMed  Google Scholar 

  57. Gaertner WB, Madoff RD, Spencer MP, Mellgren A, Goldberg SM, Lowry AC. Results of combined medical and surgical treatment of recto-vaginal fistula in Crohn’s disease. Color Dis. 2011;13(6):678–83. https://doi.org/10.1111/j.1463-1318.2010.02234.x.

    Article  CAS  Google Scholar 

  58. Roumeguère P, Bouchard D, Pigot F, et al. Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohnʼs disease: results from a prospective study. Inflamm Bowel Dis. 2011;17(1):69–76. https://doi.org/10.1002/ibd.21405.

    Article  PubMed  Google Scholar 

  59. Duff S, Sagar PM, Rao M, Dolling S, Sprakes M, Hamlin PJ. Infliximab and surgical treatment of complex anal Crohn’s disease. Color Dis. 2012;14(8):972–6. https://doi.org/10.1111/j.1463-1318.2011.02811.x.

    Article  CAS  Google Scholar 

  60. Antakia R, Shorthouse AJ, Robinson K, Lobo AJ. Combined modality treatment for complex fistulating perianal Crohn’s disease. Color Dis. 2013;15(2):210–6. https://doi.org/10.1111/j.1463-1318.2012.03124.x.

    Article  CAS  Google Scholar 

  61. Kotze PG, Albuquerque IC, da Luz Moreira A, Tonini WB, Olandoski M, Coy CSR. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn’s disease: a Brazilian multicenter observational study. Arq Gastroenterol. 2014;51(4):284–9. https://doi.org/10.1590/S0004-28032014000400004.

    Article  PubMed  Google Scholar 

  62. Bor R, Farkas K, Bálint A, et al. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn’s disease – clinical observations from a tertiary Eastern European center. Scand J Gastroenterol. 2015;50(2):182–7. https://doi.org/10.3109/00365521.2014.936033.

    Article  CAS  PubMed  Google Scholar 

  63. Haennig A, Staumont G, Lepage B, et al. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn’s disease. Color Dis. 2015;17(4):311–9. https://doi.org/10.1111/codi.12851.

    Article  CAS  Google Scholar 

  64. Yardımcı S, Kara YB, Attaallah W, Uğurlu MÜ, Yeğen ŞC. Seton drainage combined with anti-tnf therapy for perianal fistulizing Crohn’s disease, single center experience. Marmara Med J. 2016;29(2):79. https://doi.org/10.5472/MMJoa.2902.03.

    Article  Google Scholar 

  65. Schwartz DA, Wang A, Ozbay B, et al. Comparison of health care utilization and costs between patients with perianal fistulizing Crohn’s disease treated with biologics with or without previous seton placement. Inflamm Bowel Dis. 2017;23(10):1860–6. https://doi.org/10.1097/MIB.0000000000001243.

    Article  PubMed  Google Scholar 

  66. Orkin BA, Telander RL. The effect of intra-abdominal resection or fecal diversion on perianal disease in pediatric Crohn’s disease. J Pediatr Surg. 1985;20(4):343–7. http://www.ncbi.nlm.nih.gov/pubmed/4045658. Accessed 17 June 2018.

    Article  CAS  Google Scholar 

  67. Rosen MJ, Moulton DE, Koyama T, et al. Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohnʼs disease. Inflamm Bowel Dis. 2010;16(3):461–8. https://doi.org/10.1002/ibd.21067.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Hukkinen M, Pakarinen MP, Piekkala M, Koivusalo A, Rintala R, Kolho K-L. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn’s disease. J Crohns Colitis. 2014;8(8):756–62. https://doi.org/10.1016/j.crohns.2014.01.001.

    Article  PubMed  Google Scholar 

  69. Mattioli G, Pio L, Arrigo S, et al. Cone-like resection, fistulectomy and mucosal rectal sleeve partial endorectal pull-through in paediatric Crohn’s disease with perianal complex fistula. Dig Liver Dis. 2015;47(8):658–62. https://doi.org/10.1016/j.dld.2015.05.003.

    Article  PubMed  Google Scholar 

  70. Seemann NM, King SK, Elkadri A, Walters T, Fish J, Langer JC. The operative management of children with complex perianal Crohn’s disease. J Pediatr Surg. 2016;51(12):1993–7. https://doi.org/10.1016/j.jpedsurg.2016.09.021.

    Article  PubMed  Google Scholar 

  71. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the Treatment of Fistulas in Patients with Crohn’s Disease. N Engl J Med. 1999;340(18):1398–405. https://doi.org/10.1056/NEJM199905063401804.

    Article  CAS  PubMed  Google Scholar 

  72. de Groof EJ, Sahami S, Lucas C, Ponsioen CY, Bemelman WA, Buskens CJ. Treatment of perianal fistula in Crohn’s disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Color Dis. 2016;18(7):667–75. https://doi.org/10.1111/codi.13311.

    Article  Google Scholar 

  73. Marzo M, Felice C, Pugliese D, et al. Management of perianal fistulas in Crohn’s disease: an up-to-date review. World J Gastroenterol. 2015;21(5):1394. https://doi.org/10.3748/wjg.v21.i5.1394.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Sahni VA, Ahmad R, Burling D. Which method is best for imaging of perianal fistula? Abdom Imaging. 2008;33(1):26–30. https://doi.org/10.1007/s00261-007-9309-y.

    Article  PubMed  Google Scholar 

  75. Ziech M, Felt-Bersma R, Stoker J. Clinical imaging. Imaging of perianal fistulas. YJCGH. 2009;7:1037–45. https://doi.org/10.1016/j.cgh.2009.06.030.

    Article  Google Scholar 

  76. Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME. Long-term quality of life in patients with Crohnʼs disease and perianal fistulas: influence of fecal diversion. Dis Colon Rectum. 2007;50(12):2067–74. https://doi.org/10.1007/s10350-007-9006-5.

    Article  PubMed  Google Scholar 

  77. Lee MJ, Heywood N, Sagar PM, Brown SR, Fearnhead NS, pCD Collaborators. Surgical management of fistulating perianal Crohn’s disease–AUK survey. Color Dis. 2017;19(3):266–73. https://doi.org/10.1111/codi.13462.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergey Khaitov .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Khaitov, S., Ofshteyn, A. (2019). Management of Severe Anoperineal Disease. In: Hyman, N., Fleshner, P., Strong, S. (eds) Mastery of IBD Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-16755-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16755-4_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16754-7

  • Online ISBN: 978-3-030-16755-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics